Intrinsiqq
Agilon Health Inc. logo

Agilon Health Inc. (AGL) Insider Trading

Last 12 months

Insiders bought $351k on the open market and sold nothing.

Net open-market
+$351k
5 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
4 / 0
executives and directors
Last open-market buy
Mar 2026
Mar 9, 2026

Get an email when AGL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Mar 9
    Denise Zamore
    Chief Legal Officer · bought 5,535
    —
    1.3% of stake
  • Mar 9
    Girish Venkatachaliah
    Chief Technology Officer · bought 18,448
    —
    7.1% of stake
  • Mar 9
    Benjamin Shaker
    Chief Markets Officer · bought 18,448
    —
    1.4% of stake
  • Mar 2
    Benjamin Shaker
    Chief Markets Officer · bought 500,000 at $0.60
    $300k
    58% of stake
  • Nov 12, 2025
    John William Wulf
    Director · bought 81,000 at $0.63
    $51k
    28% of stake
  • Mar 14, 2025
    Steven Sell
    CEO & President · bought 42,426
    —
    11% of stake
  • Mar 14, 2025
    Benjamin Shaker
    Chief Markets Officer · bought 11,786
    —
    2.6% of stake
  • Mar 14, 2025
    Girish Venkatachaliah
    Chief Technology Officer · bought 9,429
    —
    6.5% of stake
  • Dec 13, 2024
    Karen McLoughlin
    Director · bought 25,000 at $2.20
    $55k
    52% of stake
  • Dec 11, 2024
    Silvana Battaglia
    Director · bought 25,062 at $2.01
    $50k
    61% of stake
  • Nov 25, 2024 – Dec 9, 2024
    Diana McKenzie
    Director · bought 20,000 at avg $2.25
    $45k
    52% of stake
  • Dec 5, 2024
    John William Wulf
    Director · bought 45,000 at $2.18
    $98k
    28% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AGL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Misc Health & Allied Services, NEC

Spot a number that looks wrong? Check it in AGL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AGL

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.